Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $41.85 for the day, up 7.50% from the previous closing price of $38.93. In other words, the price has increased by $7.50 from its previous closing price. On the day, 16.4 million shares were traded.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 35.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 61.11. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on January 10, 2025, Downgraded its rating to Sell and sets its target price to $25 from $24 previously.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.
On December 17, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $42.Morgan Stanley initiated its Overweight rating on December 17, 2024, with a $42 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’25 when Dudum Andrew sold 100,000 shares for $35.22 per share. The transaction valued at 3,522,300 led to the insider holds 27,918 shares of the business.
Boughton Soleil sold 4,153 shares of HIMS for $146,601 on Feb 03 ’25. The Chief Legal Officer now owns 161,497 shares after completing the transaction at $35.30 per share. On Feb 03 ’25, another insider, Chi Michael, who serves as the Chief Commercial Officer of the company, sold 2,054 shares for $35.30 each. As a result, the insider received 72,506 and left with 193,601 shares of the company.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 96.81, and their Forward P/E ratio for the next fiscal year is 80.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.36 while its Price-to-Book (P/B) ratio in mrq is 20.71.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $39.74, while it has fallen to a 52-week low of $8.51. The 50-Day Moving Average of the stock is 41.71%, while the 200-Day Moving Average is calculated to be 96.76%.
Shares Statistics:
A total of 209.44M shares are outstanding, with a floating share count of 177.52M. Insiders hold about 18.75% of the company’s shares, while institutions hold 56.81% stake in the company.
